COURSE SPECIFICATION
(Clinical Oncology&Nuclear Medicine)
Faculty of Medicine- Mansoura University
(A)
Administrative information
(1) Programmeoffering the course:
Postgraduate M.D degree of Clinical
Oncology and Nuclear Medicine/
CONM617
(2) Department offering the programme:
Clinical oncology and nuclear medicine
(3) Department responsible for teaching the
Clinical oncology and nuclear medicine
course:
(4) Part of the programme:
department
department
Second part
(5) Date of approval by the Department`s
council
(6) Date of last approval of programme
specification by Faculty council
(7) Course title:
Clinical Oncology
(8) Course code:
CONM 617 CO
(9) Total teaching hours:
410 hours
(B)
Professional information
(1)
Course Aims:
The broad aims of the course are as follows:(either to be written in items or as a paragraph)
1- Educate the candidates the concepts and terminology of clinical oncology.
2- Provide the students the principles of cancer management and decision making for
treatment policy .
3- Teach them recent advances in management of different body parts.
(2)
Intended Learning Outcomes (ILOs):
Intended learning outcomes (ILOs); Are four main categories: knowledge & understanding to be
gained, intellectual qualities, professional/practical and transferable skills.
On successful completion of the course, the candidate will be able to:
A- Knowledge and Understanding
The trainee should: know and understand:
A8:Discus principles of cancer management.
A9: Descripe recent advances in management of different body parts.
A10: Describe indications and goals of treatment with anticancer agents in primary and
metastatic malignant disorders.
A11: Explain the newer methods of cancer treatment.
2- Intellectual activities (I)
A12: Identify oncologic emergencies , supportive care of cancer patients.
The Postgraduate Degree provides opportunities for candidates to achieve and demonstrate the
A13: Describe
the recent
advances in radio-therapeutic and systemic treatment
following
intellectual
qualities:
(chemotherapy, hormone therapy, biologic agents) according to evidence basedpractice and
understand and practice clinical audit and risk management and Know the usefulness of
anticancer agents in the neo-adjuvant, concomitant, and adjuvant setting and as a radiation
sensitizer
B- Intellectual skills
B3: Recognize Clinical knowledge, that is radiological, medical, surgical and pathological,
relating to the specific body systems
B4: Distinguish the evidence based clinical practice
B5: Distinguish the indications, contraindications and potential complications of
radiotherapy and systemic therapy(chemotherapy, hormone therapy, biological agents) in
order to plan and prescribe appropriate treatment for common malignancies
B6: Evaluate the management of complications of disease processes and of different
treatment modalities.
C- Professional/practical skills
Training should give appropriate experience in the areas identified below:
C1: Distinguishes Generic modules:
• Prescription and administration of cytotoxic chemotherapy
• Professional attitudes
C2: Designs the plan of treatment to System-based site specialities:
• breast cancer
• thoracic malignancy
• upper and lower gastrointestinal (GI)
• head and neck
• sarcomas
• gynaecological oncology
• urological malignancy and germ cell tumours • neuro-oncology
• skintumours
• lymphomas
• pediatrics oncology
C3: Applies Technique-based specialities:
2D treatment techniques
3D treatment techniques.
Conformal radiotherapy.
C4: participate in an appropriate on-call rota, or other schemes of exposure to acute and
emergency oncology, in which he/she will be responsible to a named consultant(s).
D- Communication &Transferable skills
D1: Trainees must be able to.
Explain disease processes and treatment details honestly in language appropriate
to patients and their families.
Communicate clearly and efficiently both orally and in writing with medical
colleagues in other disciplines.
Maintain accurate records of consultations and other interactions with patients
and their families.
D2: Trainees must Take part in discussions in multi-disciplinary meetings.
D3: Trainees should be able to explain clearly the benefits, side effects and risks
of a course of radiotherapy.
D4 Trainees shouldAssess and advise patients attending for follow-up after
completion of treatment and advise on appropriate investigations during and
after follow-up.
(3)
Course Content:
Trimesters Subjects
First
*Principles of cancer management and
decision making for treatment policy:
surgery, radiotherapy, hormonal
therapy and chemotherapy.
* Multidisciplinary approach of
treatment.
* Recent advances in
management of cancer head
and neck:
- nasal cavity,
Lectures
Clinical
Total Teachin
Hosurs
2
10
1.5
6
1.5
0.5
-paranasal sinuses,
1.5
0.5
-nasopharnyx,
1.5
1
-oral cavity,
1.5
1
-oropharnyx,
1.5
0.5
- larynx,
1.5
0.5
-hypopharnyx
1.5
0.5
-salivary glands.
1.5
0.5
2
0.5
* Recent advances in
management of cancer lung:
-small cell lung cancer
-Non-small cell lung cancer
-Carcinoids tumors
-Large cell neuroendocrine carcinoma.
* Recent advances in
management of cancer mediastinum :
-Thymic tumors
-Germ Cell Tumors
-Mesenchymal tumors
-Neurogenic tumors
-Primary Cardiac malignancies
LaboratoryField
2
2
1
0.5
0.5
0.5
3
5.5
4.5
5.5
3.5
4.5
3.5
5.5
5.5
5.5
4.5
4.5
1.5 0.5
3.5
1.5 0.5
3
1.5 0.5
1.5 0.5
1
0.5
3
3
3
1.5 0.5
*Recent advances in
management of cancer pleura.
*Leukemias, lymphomas and plasma cell
neoplasms.
* Recent advances in management of
genitourinary system cancers:
-kidney,
- ureter,
- bladder,
-prostate,
-urethra,
- penis,
-testis
Second
* Recent advances in management of
GIT cancers:
- esophagus,
-stomach,
-pancreas,
-hepatobiliary,
-small intestine,
-colon,
-rectal
-anal region.
* Recent advances in management of
Gynecologic tumors:
- vulva,
3
3
1
9
2
0.5
3
2
0.5
6
1
0.5
2
1
1
1
3
5.5
0.5
2
3
0.5
3
0.5
5
2
0.5
2
0.5
2
2
2
2
2
2
2
0.5
0.5
0.5
0.5
0.5
0.5
1
4.5
4.5
3.5
4.5
3.5
5.5
6
4.5
4.5
3.5
2
0.5
6
- endometrium,
2
0.5
3.5
-fallopian tubes,
-gestational trophoblastic disease
-ovary
2
-vagina,
-cervix,
* Recent advances in
management of breast cancer:
-Early breast cancer
-Locally advanced breast cancer
-Metastatic breast
2
2
0.5
0.5
6
4.5
5.5
2
0.5
2
2
8
2
1
8
3
* Recent advances in
2
management of Soft tissue
sarcomas
*Principles of applications of biologic therapy 2
Third
1
1
1
8
8
0.5
5.5
*Adverse effects of treatment
2
0.5
10
*Treatment of metastatic cancer
2
0.5
10
*Bone sarcomas:
-Osteosarcoma
-Giant cells tumors
-Ewing sarcoma
1.5
0.5
1.5
0.5
1.5
0.5
4.5
4.5
4.5
-Chondrosarcoma
1.5
*Non melanomatous skin cancer
*Melanomas.
2
0.5
8
2
0.5
7.5
1.5
0.5
5.5
1.5
0.5
4.5
*Cancer of the endocrine system :
- thyroid,
-parathyroid,
-adrenals,
- pancreas,
1.5
1.5
0.5
5.5
0.5
0.5
4.5
3.5
-carcinoid.
* Neoplasms of the central nervous
system:
-Low grade gliomas
-High grade gliomas
-Meningiomas
-Ependymomas
1
-Wilm's
-Retinoblastoma
-Pediatric bone sarcomas
-Osteosarcoma
-Ewing's sarcoma
-Rhabdomyosarcoma
-Liver tumors
5.5
1.5 0.5
1.5 1
* Solid tumours of childhood:
-Neuroblastoma
5.5
1.5 0.5
-Pituitary tumors
-Orbital, ocular& optic nerve tumors.
5.5
1.5 0.5
1.5 1
4.5
5.5
1.5 0.5
-Medulloblastoma
-Spinal cord tumors
0.5
5.5
6
5
1.5 0.5
5
1.5 0.5
2
0.5
3
2
0.5
3
2
2
2
1.5
1.5
1.5
1.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
3
3
3
3
3
3
3
-Germ cell tumors
Fourth
*Paraneoplastic syndromes and
oncologic emergencies.
*Cancer of unknown primary site .
2.5
1
10.5
2.5
1
10
*Cancer in Aids and other
immunodeficiency status
*Principles of chemotherapy:
chemotherapy objectives, side effects
2.5
1
6
3
1
13
and complications of chemotherapy
*Supportive care in cancer patient.
*Administrative issues of cancer
treatment :
-Evolutionof roles for oncology nurses
- Practical issues affecting patient care
* Psychological aspects of patients with
cancer .
*Rehabilitation of cancer patients.
*Design and conduct of clinical trials
*Newer methods of cancer treatment :
-Role of stem cell in cancer
2.5
2
8
2.5
1
6
2.5
1
6
2.5
1
6
2.5
1
6
2.5
2.5 1
1
management
-Molecular and genetic approaches
2.5
-Chemical modification of radiation and
2.5
1
2.5
0.5
- Photodynamic therapy
-Particle beam radiation therapy
-Bone marrow transplantation
-Recent innovation
Teaching methods:
4.1: lectures
4.2: scientific meetings.
4.3:case presentation.
4.4: panel discussion .
4.5: club journal
2.5
2.5
2.5
8
6
6
Hyperthermia
chemotherapy
(4)
2
6
8
0.5
0.5
0.5
5
6
6
5
(5)
Assessment methods:
5.1: written exam for assessment ofKnowledge and intellectual skills
5.2: oral exam for assessment ofKnowledge and intellectual skills
5.3: clinical exam for assessment ofKnowledge , intellectual skills, practical, and
communication skills.
Assessment schedule:
Assessment 1: exam held after 30 month of registration.
Assessment 2: exam held after 30 month of registration.
Assessment 3: exam held after 30 month of registration.
Percentage of each Assessment to the total mark:
Written exam: 60%
Clinical exam: 20%
Oral exam:
(6)
20%
References of the course:
6.1: Text books:
●PerezCA, BradyLW,HalperinEC,etal.,editors.Principles and
Practice of RadiationOncology. 5thed. Philadelphia:Lippincott
Williams&Wilkinns; 2008.
●Hansen EK and Roach M.: Handbook of Evidence-based Radiation
Oncology.1st edition. New York: springer science+ business media,
LLC; 2007.
●Casciato DA, editor.Manual of clinical oncology.6th edition.
Philadelphia: Lippincott Williams&Wilkins; 2009.
●DeVita VT, Hellman S, Rosenberg SA, editors. Principles
andPractice of Oncology.8th ed.Philadelphia: Lippincott; 2008.
6.2: Journals:
 Journal of clinical oncology
 International journal of radiation oncology, radiobiology & physics.
6.3: Websites:
 www.asco.org
 www.esmo.org
(7)
Facilities and resources mandatory for course completion:
Candidates and their learning are supported in a number of ways:
□Candidates logbook
□ Programme Specification
□Extensive library and other learning resources
□Computer laboratories with a wide range of software
□Intranet with a wide range of learning support material
□MSc/MD Dissertation Supervisor
Course coordinator:
Head of the department:
Date:
P.S. This specificat